2022
DOI: 10.1021/acs.joc.2c02047
|View full text |Cite
|
Sign up to set email alerts
|

Trimethylene Methane Dianion Equivalent for the Asymmetric Consecutive Allylation of Aldehydes: Applications to Prins-Driven Macrocyclizations for the Synthesis of Bryostatin 1 and Analogues

Abstract: We report a one-step (one-flask) generation and reaction of a bifunctional allylating reagent, a trimethylene methane dianion equivalent, that provides a route for the asymmetric 2-(trimethylsilylmethyl) allylation of aldehydes. The product of the first aldehyde allylation process is then set to engage in a second separate aldehyde allylation, providing an improved Prins macrocyclization strategy both for the scalable synthesis of bryostatin 1 and for the total synthesis of a new potent bryostatin analogue.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 69 publications
0
1
0
Order By: Relevance
“…This efficient ringclosing strategy was recently used to prepare more than 20 C-13modified bryostatin analogues for evaluation as protein kinase C modulators (Scheme 7). 21 Several tested analogues were found to display good clinical potential for enhancing antigen-targeted immunotherapies. The development of a novel bifunctional trichlorosilane reagent 22 not only improved their previous route for the A-ring fragment but also provided access to a structurally more simplified des-A-ring analogue 40, which retains excellent affinity for several protein kinase C isoforms as compared to the parent natural product.…”
mentioning
confidence: 99%
“…This efficient ringclosing strategy was recently used to prepare more than 20 C-13modified bryostatin analogues for evaluation as protein kinase C modulators (Scheme 7). 21 Several tested analogues were found to display good clinical potential for enhancing antigen-targeted immunotherapies. The development of a novel bifunctional trichlorosilane reagent 22 not only improved their previous route for the A-ring fragment but also provided access to a structurally more simplified des-A-ring analogue 40, which retains excellent affinity for several protein kinase C isoforms as compared to the parent natural product.…”
mentioning
confidence: 99%